Thursday, May 29, 2014 12:12:17 PM
The MMTC press release did not state that the joint effort with the university was a Phase 1 clinical trial. Here is the lead statement for the press release - Micro Imaging Technology Enters Phase 1 of Its Collaboration With Northern Michigan University.
Information regarding clinical trials testing as established by the Federal Drug Administration can be found at the following URL.
http://www.fda.gov/drugs/resourcesforyou/consumers/ucm143534.htm
The collaboration does not involve drug testing. Upon obtain staphylococcus identifiers, it is my understanding that the company will work with the AOAC Research Institute to validate the identification process.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM